Quick Answer
Alaunos Therapeutics, Inc. reported Shares Outstanding of 2.35 million shares for fiscal year 2025.
Alaunos Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 2.35M | +46.7% |
| 2024 | 1.60M | +0.0% |
| 2023 | 1.60M | -90.0% |
| 2022 | 16.03M | -92.6% |
| 2021 | 216.13M | +0.7% |
| 2020 | 214.59M | +18.0% |
| 2019 | 181.80M | +12.9% |
| 2018 | 161.07M | +12.9% |
| 2017 | 142.66M | +7.8% |
| 2016 | 132.38M | +0.5% |
| 2015 | 131.72M | +26.1% |
| 2014 | 104.45M | +4.3% |
| 2013 | 100.16M | +20.3% |
| 2012 | 83.24M | +20.3% |
| 2011 | 69.21M | +42.8% |
| 2010 | 48.47M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 2.21M | +37.8% | +6.3% |
| June 30, 2025 | 2.07M | +29.6% | +29.6% |
| March 31, 2025 | 1.60M | -90.0% | +0.0% |
| December 31, 2024 | 1.60M | +0.0% | +0.0% |
| September 30, 2024 | 1.60M | -99.3% | +0.0% |
| June 30, 2024 | 1.60M | -99.3% | -90.0% |
| March 31, 2024 | 16.01M | -93.3% | +900.0% |
| December 31, 2023 | 1.60M | -99.3% | -99.3% |
- Alaunos Therapeutics, Inc. showed an increase of +46.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Alaunos Therapeutics, Inc.’s shares outstanding has declined by 95.2% (from 48.47 million shares to 2.35 million shares).
- The most recent figure is from Alaunos Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: